Get in touch

Tiefenbacher Group at CPHI Frankfurt 2025

Tiefenbacher Group at CPHI Frankfurt 2025

After weeks of preparation, the countdown is finally over. Next week, our Tiefenbacher Group team will be at CPHI in Frankfurt. Before we unveil our new booth design, take a look back at some impressions from last year’s CPHI: engaging discussions, inspiring meetings, and many valuable connections with our global partners. From 28th of October […]

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy ® (Tegomil Fumarate) in Germany

Tiefenbacher Group Neuraxpharm Riulvy Germany

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy® (Tegomil Fumarate) in GermanyAt Tiefenbacher Group, we are deeply committed to developing and delivering high-quality, value-added pharmaceuticals that improve the lives of patients worldwide. In collaboration with our trusted partner Neuraxpharm we are proud to announce the successful launch of Riulvy ® (Tegomil Fumarate) 174 mg […]

Tiefenbacher Group Career Stories No 3

Badri Narayana, Quality Assurance Manager

Get to know Badri Narayana, Quality Assurance Manager at Tiefenbacher Group!”At TiefenbacherGroup, it’s our people who drive innovation, collaboration, and impact across the globe. That’s why we’re excited to share another story in our video series highlighting the individuals who make Tiefenbacher a unique place to work and grow. In this episode Badri talks about […]

Tiefenbacher Group Career Stories No 2

Johanna Hansen, AI Project Manager

Get to know Johanna Hansen, AI Project Manager at Tiefenbacher Group!”At Tiefenbacher Group, it’s our people who shape innovation, company culture and our impact on patients around the world. That’s why we’re excited to continue our video series giving you a behind-the-scenes look at the individuals who make Tiefenbacher a unique place to work and […]

Tiefenbacher Group Career Stories No 1

Sayan Sarkar, Head of Global Digitalization & AI at Tiefenbacher Group

Get to know Sayan Sarkar, Head of Global Digitalization & AI at Tiefenbacher Group!”At Tiefenbacher Group, it’s our employees who shape innovation, company culture, and impact on patients around the world. That’s why we’re excited to launch a new video series giving you a behind-the-scenes look at the people working at Tiefenbacher. In this episode […]

Pioneering Healthcare at Tiefenbacher Group

Tiefenbacher Group - A man in a light blue shirt sits and gestures while speaking in a bright office. A quote by Dr. Kristian Ruepp highlights curiosity, excellence, and patient-centric drug development in pharmaceutical healthcare solutions.

At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more […]

Tiefenbacher Group celebrates Pharmacy Day

Tiefenbacher Group - A man in a denim shirt browses medicine and health products on a shelf in a pharmacy, while a pharmacist stands in the background behind the counter, highlighting access to finished dosage forms and API distribution.

Last Saturday, Germany and Tiefenbacher Group celebrated Pharmacy Day – Tag der Apotheke!We at Tiefenbacher Group want to take this moment to thank all pharmacists for their invaluable contribution to global health. Every day, your expertise and commitment make a critical difference in people’s lives. As a fully integrated pharmaceutical company, we are proud to […]

Tiefenbacher Group World Environment Day

Tiefenbacher Group - Close-up of a wind turbine at sea during sunset, with other turbines in the background. The warm sky reflects off the ocean, echoing the innovative energy found in pharmaceutical healthcare solutions.

World Environment Day 2025 – Our Commitment to a Healthier PlanetJune 5 marks World Environment Day, established by the United Nations in 1972 to raise global awareness and inspire action for the protection of our environment. This year’s motto is “Restore Our Earth”, highlighting the urgent need to reverse environmental degradation and build a more […]

Tiefenbacher Group’s New Packaging Line in Cyprus

Tiefenbacher Group - A modern packaging machine for pharmaceutical healthcare solutions operates in a clean, well-lit factory with gray floors, white ceilings, transparent panels, conveyor belts, and colored indicator lights.

Tiefenbacher Group is expanding the production capacity with a new packaging line in Cyprus to make medicines more affordable and available.At Tiefenbacher Group, we believe that access to affordable, high-quality medicine should never be limited by production capacity. That’s why we’re thrilled to share that this new addition is a key step in enhancing capabilities […]

Tiefenbacher Group celebrating new buildings in Hyderabad

Tiefenbacher Group - A modern, multi-story building with white walls and large blue-tinted glass windows, labeled "Laboratories," reflects a family-owned pharmaceutical company focused on finished dosage forms. The entrance features stairs and a sleek glass canopy.

Exciting News from Tiefenbacher Group!We are thrilled to announce the grand inauguration of our newly constructed development and production facilities in Hyderabad, India! This marks a significant milestone in our mission to develop and manufacture high-quality, affordable pharmaceuticals for patients worldwide. Our new facilities Our state-of-the-art complex spans 4,000 m², featuring cutting-edge laboratories and production […]

Exciting Days at DCAT in New York!

Tiefenbacher Group - A group of seven smiling people in business attire take a selfie on a busy city street. A banner reads, "Tiefenbacher sends greetings from the DCAT." The TIEFENBACHER GROUP logo highlights this family-owned pharmaceutical company.

Our team sends greetings and impressions from the Big Apple!As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group team has had the privilege of engaging in insightful conversations, strengthening partnerships, and showcasing our latest innovations to make pharmaceuticals more […]

Tiefenbacher Group celebrating World Cancer Day

Tiefenbacher Group - A doctor smiles warmly at a young child wearing a pink headscarf in a bright medical setting, reflecting TIEFENBACHER GROUP’s commitment to pharmaceutical healthcare solutions on World Cancer Day.

The 4th of February is the day to raise awareness of cancer worldwide.Tiefenbacher Group joins the initiative led by the Union for International Cancer Control (UICC) to remind people that cancer has a global impact of around 20 million new cases each year and is a major public health challenge. The new World Cancer Day […]

Tiefenbacher Group wishes you a happy new year!

Tiefenbacher Group - White text on a blue background reads "Tiefenbacher Group" with a circular dotted logo to the left, highlighting "A Year in Review" and their commitment to pharmaceutical healthcare solutions.

As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year’s highlights with you. This year we celebrated many achievements: several international launches of prescription medicines, the preparation for Bilastine’s over-the-counter entry in Germany, the renovation of our Hamburg offices, and the construction […]

Tiefenbacher Group celebrating World Diabetes Day

Diabetes and well-being is the theme for World Diabetes Day 2024-26.On November 14th, we join the global community in recognizing World Diabetes Day, a day dedicated to raising awareness about the impact of diabetes worldwide. Led by the International Diabetes Federation (IDF), World Diabetes Day emphasizes the importance of education, early diagnosis, and access to […]

Tiefenbacher Group CPHI Milan 2024

Tiefenbacher Group - A large group of smiling people in white polo shirts with blue lanyards pose together at the Tiefenbacher Group booth at CPHI Milan 2024, showcasing their family-owned pharmaceutical company’s commitment to patient-centric drug development.

Tiefenbacher Group reflecting on incredible days at CPHI in Milan!We had the pleasure of engaging in many inspiring conversations over the course of the three days, reconnecting with familiar faces and forming exciting new connections. A highlight was our new booth where we introduced our current product portfolio and our innovations in raw materials, finished […]

Pioneering Healthcare at Tiefenbacher Group

Tiefenbacher Group - A man in a suit sits thoughtfully in a modern office with large windows. Text highlights the importance of pharmaceutical quality standards and Tiefenbacher Group’s leadership in finished dosage forms and patient-centric drug development since 1963.

At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more […]

OYSTA receives UX Design Award 2024

Tiefenbacher Group - A group of thirteen people in business attire stand smiling together outside a historic Gothic-style building, representing leaders in pharmaceutical healthcare solutions and patient-centric drug development.

We are happy to announce that our beloved OYSTA project has been awarded with the prestigious UX Design Award.Thanks to the outstanding work of our partner Star, a global technology consultancy, which takes care of OYSTA Digital Service, the companion to our OYSTA Dosage Manager. In recognition of the exceptional design and innovation behind the […]

Pioneering Healthcare at Tiefenbacher Group

Tiefenbacher Group - A man in a blue shirt stands by a window, softly smiling. A quote about pioneering pharmaceutical healthcare solutions is displayed beside him, along with the Tiefenbacher Group logo and the caption "Pioneering Healthcare at Tiefenbacher Group.

Curiosity Driven, Excellence Focused, Patient CenteredAt Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose […]

New laboratory and production site for Oncology medicines

Tiefenbacher Group - A modern building with a blue and white geometric facade, large glass windows, and a loading dock where a truck is parked; ideal for API distribution of finished dosage forms, with a partly cloudy sky above.

Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?The new complex is located at Tiefenbacher Laboratories in Hyderabad, India, and covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment […]

Tiefenbacher Group celebrating US Independence Day

Today is one of the most important public holidays in the United States of America, celebrating its freedom. At the 4th July 1776, by the adoption of the Declaration of Independence, it declared its independence from Great Britain.  On this day, US-Americans all over the world come together to celebrate the spirit of American freedom and […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and boost 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Did you know that TIEFENBACHER GROUP heavily invests in its in-house production capacities for high-quality pharmaceuticals? We continuously expand in novel technologies and capabilities to improve quality […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

WORLD HEALTH DAY @ TIEFENBACHER GROUP

Tiefenbacher Group - A diverse group of five older adults stand outdoors in a park, laughing and smiling together. The Tiefenbacher Group logo is displayed in the top left corner, reflecting their commitment to innovative pharmaceutical healthcare solutions.

World Health Day is on the 7th of April each year – this day marks the anniversary of the World Health Organization which was founded in 1948.Today we celebrate World Health Day. This Day marks the anniversay of the World Health Organization (WHO). In times of a global pandemic and a cruel war in Europe, […]

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for the generic of Rivaroxaban 2.5 mg, 10 mg, 15 mg and 20 mg film-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower […]

Get in touch